
JAMA Ophthalmology : Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy
JAMA Network
00:00
Exploring mTOR Inhibitors in Retinal Diseases
This chapter examines the role and popularity of mTOR inhibitors in treating conditions like cancers and transplant rejections, with an eye towards their potential benefits for proliferative vitreoretinopathy (PVR). The discussion includes the motivations for their use, ongoing research efforts, and the advantages of using these drugs in surgical contexts.
Transcript
Play full episode